Swipe om te navigeren naar een ander artikel
EQ-5D™ is a trade mark of the EuroQol Group. All EQ-5D products are distributed exclusively from the EuroQol Executive Office (email@example.com).
This article introduces the new 5-level EQ-5D (EQ-5D-5L) health status measure.
EQ-5D currently measures health using three levels of severity in five dimensions. A EuroQol Group task force was established to find ways of improving the instrument’s sensitivity and reducing ceiling effects by increasing the number of severity levels. The study was performed in the United Kingdom and Spain. Severity labels for 5 levels in each dimension were identified using response scaling. Focus groups were used to investigate the face and content validity of the new versions, including hypothetical health states generated from those versions.
Selecting labels at approximately the 25th, 50th, and 75th centiles produced two alternative 5-level versions. Focus group work showed a slight preference for the wording ‘slight-moderate-severe’ problems, with anchors of ‘no problems’ and ‘unable to do’ in the EQ-5D functional dimensions. Similar wording was used in the Pain/Discomfort and Anxiety/Depression dimensions. Hypothetical health states were well understood though participants stressed the need for the internal coherence of health states.
A 5-level version of the EQ-5D has been developed by the EuroQol Group. Further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Devlin, N., Hansen, P., & Herbison, P. (2000). Variations in self-reported health status: Results from a New Zealand survey. The New Zealand Medical Journal,113, 517–520. PubMed
Agt, H. M., & van Bonsel, G. J. (2005). The number of levels in the descriptive system. In P. Kind, R. Brooks, & R. Rabin (Eds.), EQ-5D concepts and methods: A developmental history (pp. 29–33). Dordrecht: Springer. CrossRef
Espallargues, M., Czoski-Murray, C. J., Bansback, N. J., Carlton, J., Lewis, G. M., Hughes, L. A., et al. (2005). The impact of age-related macular degeneration on health status utility values. Investigative Ophthalmology & Visual Science,46, 4016–4023. CrossRef
Lissitz, R. W., & Green, S. B. (1975). Effect of the number of scale points on reliability: A Monte Carlo approach. Journal of Applied Psychology,60, 10–13. CrossRef
Nishisato, S., & Torii, Y. (1970). Effects of categorizing continuous normal variables on the product-moment correlation. Japanese Psychology Research,13, 45–49.
Szabo, S. (1996). World Health Organization Quality of Life (WHOQOL) assessment instrument. In B. Spilker (Ed.), Quality of life and of life and pharmaeconomics in clinical trials (pp. 355–362). Philadelphia: Lippincott-Raven.
Keller, S. D., Ware, J. E., Jr., Gandek, B., Aaronson, N. K., Alonso, J., Apolone, G., et al. (1998). Testing the equivalence of translations of widely used response choice labels: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology,51, 933–944. PubMedCrossRef
Grbich, Carol. (1999). Qualitative research in health: An introduction. St Leonards, N.S.W.: Allen & Unwin.
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- Springer Netherlands